OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2023
(5)
2025
(3)
2022
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Geographics and bacterial networks differently shape the acquired and latent global sewage resistomes.
Not available
S-EPMC12639157
|
biostudies-literature
Cite
Unveiling the global urban virome through wastewater metagenomics.
Not available
S-EPMC12663323
|
biostudies-literature
Cite
Clinical practice selectively follows acute appendicitis guidelines.
Not available
S-EPMC9888346
|
biostudies-literature
Cite
Techniques for mesoappendix transection and appendix resection: insights from the ESTES SnapAppy study.
Not available
S-EPMC9925585
|
biostudies-literature
Cite
Surgical management of acute appendicitis during the European COVID-19 second wave: safe and effective.
Not available
S-EPMC9851576
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10156147
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets